Efficacy of intravitreal Aflibercept in patients with neovascular AMD who were previously treated with Ranibizumab based on a Treat and Extend protocol

被引：0
|
作者：
Turksever, C.
Prunte, C.
Hatz, K.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2015年 / 93卷
关键词：
D O I：
10.1111/j.1755-3768.2015.0396
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
ABS15-0396
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy of Intravitreal Aflibercept in Patients with Neovascular AMD Who Were Previously Treated with Ranibizumab Based on a Treat and Extend Protocol
    Turksever, Cengiz
    Pruente, Christian
    Hatz, Katja
    OPHTHALMOLOGICA, 2016, 236 : 19 - 20
  • [2] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Alaa Din Abdin
    Shady Suffo
    Fatima Asi
    Achim Langenbucher
    Berthold Seitz
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1671 - 1677
  • [3] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Abdin, Alaa Din
    Suffo, Shady
    Asi, Fatima
    Langenbucher, Achim
    Seitz, Berthold
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (08) : 1671 - 1677
  • [4] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Rachel Hui Fen Lim
    Bhaskar Gupta
    Peter Simcock
    International Journal of Ophthalmology, 2017, (03) : 423 - 426
  • [5] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Lim, Rachel Hui Fen
    Gupta, Bhaskar
    Simcock, Peter
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (03) : 423 - 426
  • [6] Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
    Avery, Robert L.
    Castellarin, Alessandro A.
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Pieramici, Dante Joseph
    See, Robert
    Couvillion, Stephen
    Nasir, Ma'an A.
    Rabena, Melvin D.
    Le, Kha
    Maia, Mauricio
    Visich, Jennifer E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (12) : 1636 - 1641
  • [7] Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial
    Hatz, Katja B.
    Pruente, Christian
    Binningen, Vistaklinik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Intravitreal ranibizumab for neovascular agerelated macular degeneration with a Treat and Extend protocol: anatomical and functional results
    Meillon, C.
    Koehrer, P.
    Isaico, R.
    Bonnabel, A.
    Bron, A. M.
    Creuzot-Garcher, C.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [9] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [10] Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept
    Mimura, Kensuke
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Akiyama, Hideo
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 121 - 127
12345